Med24
metabolic-therapy 30. 10. 2026 • 2 min read • Revista clinica espanola (PubMed)

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

MASH-riskin tunnistaminen: Tutkimus Ruotsista

This study investigated cardiometabolic abnormalities in normal-weight adults. The research included 163,254 Spanish workers aged 18-69 years who underwent occupational health examinations. Individuals with a BMI between 18.5 and 24.9 kg/m² were included, and cardiometabolic abnormalities were defined by the presence of hypertension, dyslipidemia, or hyperglycemia. Sociodemographic and lifestyle factors, including smoking status, alcohol intake, physical activity, and Mediterranean diet adherence, were assessed.

Study Population and Assessment

A total of 49.0% of the normal-weight participants presented at least one cardiometabolic abnormality. This prevalence was higher in men (54.3%) compared to women (44.5%). Several factors were associated with increased risk, including male gender, older age, smoking, low physical activity, poor Mediterranean diet adherence, and high alcohol consumption. Lower occupational social class was also linked to greater risk.

Sponsored content

Key Findings and Recommendations

The study highlights the significant proportion of normal-weight individuals with cardiometabolic abnormalities. It suggests a need to consider factors beyond BMI in assessing cardiovascular risk. Preventive strategies should include metabolic screening and lifestyle assessments for all individuals, irrespective of weight status.

Original Scientific Source
Revista clinica espanola (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Advertisement